Pediatric immunity refers to the complex and dynamic defense mechanisms that protect children from infections and maintain overall health. The immune system in children undergoes developmental changes from birth through adolescence, adapting to confront diverse pathogens while avoiding inappropriate responses to harmless substances. Neonatal immunity is initially influenced by maternal antibodies transferred during pregnancy and breastfeeding, providing passive protection. As infants grow, their immune system matures, and they develop active immunity through vaccination and exposure to pathogens. Pediatric immunity includes innate and adaptive components, involving various immune cells, antibodies, and cytokines. Early exposure to microbes helps shape the immune system's ability to distinguish between self and non-self, fostering tolerance. Vaccination plays a crucial role in pediatric immunity, preventing severe infectious diseases. Factors such as nutrition, genetics, and environmental exposures also impact immune development in children. Understanding pediatric immunity is essential for optimizing vaccination strategies, managing infections, and promoting overall well-being in pediatric populations. Ongoing research continues to enhance our knowledge of pediatric immune responses and inform strategies to improve child health.
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Title : Overcoming biophysical characterization challenges of small antigens in dilute vaccine formulations
Eric Kemp, Merck & Co., United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : A combined LC-MS and immunoassay approach to characterize preservative-induced destabilization of human papillomavirus virus-like particles adsorbed to an aluminum-salt adjuvant
Ria T Caringal, University of Kansas, United States